To Buy - Medical Stocks

: With a projected 16% upside from analysts at U.S. News , Lilly is viewed as a high-speed growth stock despite broader pharma volatility. 2. Income & Stability: AbbVie (ABBV)

: Its growth is currently driven by two blockbuster immunosuppressants, Skyrizi and Rinvoq , which are projected to reach peak sales exceeding those of its former lead drug, Humira. medical stocks to buy

For conservative investors, is a favored "forever stock" due to its consistent performance and dividend track record. : With a projected 16% upside from analysts at U

: The company plans to build six new manufacturing plants in the U.S. to meet surging demand. Skyrizi and Rinvoq